BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21303932)

  • 1. Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH.
    White K; Loughlin L; Maqbool Z; Nilsen M; McClure J; Dempsie Y; Baker AH; MacLean MR
    Physiol Genomics; 2011 Apr; 43(8):417-37. PubMed ID: 21303932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.
    Dempsie Y; MacRitchie NA; White K; Morecroft I; Wright AF; Nilsen M; Loughlin L; Mair KM; MacLean MR
    Cardiovasc Res; 2013 Jul; 99(1):24-34. PubMed ID: 23519266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serotonin transporter, gender, and 17β oestradiol in the development of pulmonary arterial hypertension.
    White K; Dempsie Y; Nilsen M; Wright AF; Loughlin L; MacLean MR
    Cardiovasc Res; 2011 May; 90(2):373-82. PubMed ID: 21177701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension.
    White K; Johansen AK; Nilsen M; Ciuclan L; Wallace E; Paton L; Campbell A; Morecroft I; Loughlin L; McClure JD; Thomas M; Mair KM; MacLean MR
    Circulation; 2012 Aug; 126(9):1087-98. PubMed ID: 22859684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogen receptor alpha in pulmonary hypertension.
    Wright AF; Ewart MA; Mair K; Nilsen M; Dempsie Y; Loughlin L; Maclean MR
    Cardiovasc Res; 2015 May; 106(2):206-16. PubMed ID: 25765937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.
    Yue Y; Zhang Z; Zhang L; Chen S; Guo Y; Hong Y
    Cardiovasc Pathol; 2018; 37():15-25. PubMed ID: 30195228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA microarray and signal transduction analysis in pulmonary artery smooth muscle cells from heritable and idiopathic pulmonary arterial hypertension subjects.
    Yu J; Wilson J; Taylor L; Polgar P
    J Cell Biochem; 2015 Mar; 116(3):386-97. PubMed ID: 25290246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serotonin transporter (SERT) gene polymorphism and idiopathic pulmonary arterial hypertension: a meta-analysis and review of the literature.
    Zhang H; Xu M; Xia J; Qin RY
    Metabolism; 2013 Dec; 62(12):1867-75. PubMed ID: 24075737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females.
    Dempsie Y; Nilsen M; White K; Mair KM; Loughlin L; Ambartsumian N; Rabinovitch M; Maclean MR
    Respir Res; 2011 Dec; 12(1):159. PubMed ID: 22185646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.
    Willers ED; Newman JH; Loyd JE; Robbins IM; Wheeler LA; Prince MA; Stanton KC; Cogan JA; Runo JR; Byrne D; Humbert M; Simonneau G; Sztrymf B; Morse JA; Knowles JA; Roberts KE; McElroy JJ; Barst RJ; Phillips JA
    Am J Respir Crit Care Med; 2006 Apr; 173(7):798-802. PubMed ID: 16339917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nur77 downregulation triggers pulmonary artery smooth muscle cell proliferation and migration in mice with hypoxic pulmonary hypertension via the Axin2-β-catenin signaling pathway.
    Nie X; Tan J; Dai Y; Mao W; Chen Y; Qin G; Li G; Shen C; Zhao J; Chen J
    Vascul Pharmacol; 2016 Dec; 87():230-241. PubMed ID: 27871853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.
    Morecroft I; Murray A; Nilsen M; Gurney AM; MacLean MR
    Br J Pharmacol; 2009 Aug; 157(7):1241-9. PubMed ID: 19508393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism.
    Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X
    J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter.
    Guignabert C; Tu L; Izikki M; Dewachter L; Zadigue P; Humbert M; Adnot S; Fadel E; Eddahibi S
    FASEB J; 2009 Dec; 23(12):4135-47. PubMed ID: 19679640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in the serotonin transporter protein (SERT) gene in patients with pulmonary arterial hypertension.
    Baloira A; Núñez M; Cifrian J; Vilariño C; Ojeda M; Valverde D
    Arch Bronconeumol; 2012 Mar; 48(3):77-80. PubMed ID: 22177971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho.
    MacLean MR; Fanburg B; Hill N; Lazarus HM; Pack TF; Palacios M; Penumatsa KC; Wring SA
    Compr Physiol; 2022 Aug; 12(4):4103-4118. PubMed ID: 36036567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serotonin transporter promotes a pathological estrogen metabolic pathway in pulmonary hypertension via cytochrome P450 1B1.
    Johansen AK; Dean A; Morecroft I; Hood K; Nilsen M; Loughlin L; Anagnostopoulou A; Touyz RM; White K; MacLean MR
    Pulm Circ; 2016 Mar; 6(1):82-92. PubMed ID: 27162617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of a combined 5-HT1B receptor/SERT antagonist in experimental pulmonary hypertension.
    Morecroft I; Pang L; Baranowska M; Nilsen M; Loughlin L; Dempsie Y; Millet C; MacLean MR
    Cardiovasc Res; 2010 Feb; 85(3):593-603. PubMed ID: 19736308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.